Project archive

The focus of the Fraunhofer ITEM researchers in the ImmunAvatar project is on mimicking IBD. The use of both healthy tissue and tissue from IBD patients enables the identification of disease-specific differences, which can also be modulated in the model.

The Fraunhofer project FibroPaths® aims to enable rapid and safe development of antifibrotic drugs.

The aim of the MyCellFight project is to develop a fully automated immune chip able to predict the specific immune responses of individuals.

Together with several industry partners, Fraunhofer ITEM scientists published novel data on neoepitope biomarkers of type I, III and VI collagen formation or degradation in precision-cut lung slices (PCLS) from patients with Pulmonary fibrosis.

Biomedical researchers are exploring alternative ways of obtaining such immune cells of human origin. Prof. Lachmann and his team have developed a new method laying a foundation for producing them in consistent quality and on large scale.

Brain regeneration in focus: REGENERAR develops epigenetic tools to convert cells into functional neurons for innovative therapies.

CLH report template implemented in IUCLID: Fraunhofer ITEM improves efficiency and data reuse in chemical risk assessment.

Industrial chemicals in food: the SCREENER project assesses emerging risks and evaluates potential health impacts across Europe.

PFAS in focus: benefits, risks and new assessment approaches – Fraunhofer ITEM researches health impacts and develops sustainable alternatives.